Stockscreener 앱 받기
24.49
1.07%
0.26
시장 영업 전:
25.50
1.01
+4.12%
Beam Therapeutics Inc 주식(BEAM)의 최신 뉴스
Global DNA Read, Write and Edit Market to Surge to $67.7 Billion by 2030, Driven by CRISPR Advances, Genomic Diagnostics and Expanding Clinical Applications - GlobeNewswire Inc.
Beam Therapeutics CEO Sells Over $700K in Stock - National Today
Beam Therapeutics Insider Sells $146K in Shares - National Today
JonesTrading Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $35 - Moomoo
Beam Therapeutics CEO Evans sells $739k in stock By Investing.com - Investing.com Australia
Beam Therapeutics (NASDAQ:BEAM) Insider Amy Simon Sells 6,700 Shares of Stock - MarketBeat
John Evans Sells 30,078 Shares of Beam Therapeutics (NASDAQ:BEAM) Stock - MarketBeat
Beam Therapeutics (NASDAQ:BEAM) Insider Christine Bellon Sells 5,956 Shares - MarketBeat
Bethany Cavanagh (Beam Therapeutics) sells $79,688 in BEAM stock By Investing.com - Investing.com Australia
Beam Therapeutics CEO Evans sells $739k in stock - Investing.com
Amy Simon, Beam Therapeutics CMO, sells $164,686 in stock - Investing.com
Beam Therapeutics president sells $290k in shares - investing.com
[Form 4] Beam Therapeutics Inc. Insider Trading Activity - stocktitan.net
Bethany Cavanagh (Beam Therapeutics) sells $79,688 in BEAM stock - Investing.com
Beam Therapeutics (BEAM) CMO covers tax obligations via 6,700-share sale - stocktitan.net
Beam Therapeutics (BEAM) SVP auto-sells shares to cover RSU tax obligations - stocktitan.net
Beam Therapeutics (BEAM) CLO auto-sells 5,956 shares for RSU tax withholding - stocktitan.net
Beam Therapeutics (BEAM) president’s 11,810-share sale covers RSU taxes - stocktitan.net
BEAM SEC FilingsBeam Therapeutics Inc. 10-K, 10-Q, 8-K Forms - stocktitan.net
Beam Therapeutics Inc. (BEAM) Stock Price, News, Quote & History - Yahoo! Finance Canada
SG Americas Securities LLC Boosts Beam Therapeutics Stake by 139% - National Today
SG Americas Securities LLC Acquires 60,249 Shares of Beam Therapeutics Inc. $BEAM - MarketBeat
Beam Therapeutics Inc. (BEAM) stock price, news, quote and history - Yahoo Finance Australia
Intellia Therapeutics, Inc. (NTLA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Beam Therapeutics Inc. (BEAM) interactive stock chart - sg.finance.yahoo.com
Beam Therapeutics (NASDAQ: BEAM) awards 20,000 RSUs to Chief Legal Officer - stocktitan.net
Beam Therapeutics (BEAM) awards 20,000 RSUs to SVP Bethany Cavanagh - stocktitan.net
Beam Therapeutics (BEAM) awards 31,750 RSUs to Chief Medical Officer Amy Simon - stocktitan.net
CFO of Beam Therapeutics (NASDAQ: BEAM) awarded 31,750 RSUs - stocktitan.net
Beam Therapeutics (BEAM) grants president 40,000 restricted stock units - stocktitan.net
Beam Therapeutics (BEAM): Among the stocks that could 10x over the next 5 years - MSN
Insider Selling: Beam Therapeutics (NASDAQ:BEAM) CEO Sells 25,000 Shares of Stock - MarketBeat
Beam Therapeutics (BEAM): Among the Stocks That Could 10x Over the Next 5 Years - Yahoo Finance
Beam Therapeutics Insider Sold Shares Worth $1,128,315, According to a Recent SEC Filing - Moomoo
Beam Therapeutics shares climb after positive BEAM-302 trial update - MSN
BEAM Stock Price, Quote & Chart | BEAM THERAPEUTICS INC (NASDAQ:BEAM) - ChartMill
Beam (BEAM) Reports Promising Data from BEACON Trial in Sickle C - GuruFocus
Beam Therapeutics publishes sickle cell therapy trial data By Investing.com - Investing.com Australia
Why Is BEAM Stock Edging Higher After Hours Today? - Stocktwits
Beam Therapeutics CEO Evans sells $1.1m in stock By Investing.com - in.investing.com
Beam Therapeutics CEO Evans sells $1.1m in stock - investing.com
Beam Therapeutics (BEAM) CEO sells 50K shares, gains 90K RSUs - stocktitan.net
Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of Medicine - The Manila Times
In 31 sickle cell patients, Beam saw no severe pain crises after risto-cel - stocktitan.net
[144] Beam Therapeutics Inc. SEC Filing - stocktitan.net
ETRADE Financial (NASDAQ: BEAM) insider sales and restricted vesting - stocktitan.net
BEAM (NASDAQ: BEAM) affiliate notifies sale of 25,000 shares via option exercise - stocktitan.net
Beam to advance gene-editing drug to pivotal development - MSN
BEAM (NASDAQ: BEAM) insider schedules 25,000-share sale after option exercise - stocktitan.net
Beam Therapeutics gains on clinical update as gene therapy hits protective protein levels - MSN
0.47%
2.75%
자본화:
|
볼륨(24시간):